FDA's bi­o­log­ics chief stress­es need for vac­cine trans­mis­sion da­ta de­spite high costs to gen­er­ate

In­cor­po­rat­ing dis­ease trans­mis­sion da­ta in­to vac­cine tri­al de­signs could add to their ben­e­fit-risk cal­cu­lus, even though it will like­ly make vac­cines more cost­ly to de­vel­op …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER